Oppenhoff advises shareholders of Hermann Maschinenbautechnologie on investment by VORSPRUNG

Oppenhoff has advised the shareholders of Hermann GmbH Maschinenbautechnologie (HemaTec), Germany's leading manufacturer in the field of hydraulic steel engineering, on the investment by the financial investor VORSPRUNG. The sellers are remaining on board and, together with the investor, will expand HemaTec's pioneering role in hydraulic steel engineering.

Günther Hastaedt, Managing Director of HemaTec, commented: “In VORSPRUNG, we have found a long-term partner which, together with its family investors, has the same entrepreneurial mindset as we founders. Together, we will continue to extend HemaTec's success story and exploit the enormous market potential in German hydraulic steel engineering. We are very much looking forward to the years to come. We have Oppenhoff and its team led by Gabriele Fontane and Sebastian Zeeck to thank for clinching the deal. Sebastian Zeeck successfully built bridges and found solutions for all open negotiation points under extreme time pressure."

Oppenhoff’s Dr. Sebastian Zeeck commented: "We are pleased to have been able to successfully close this complex transaction for our clients. This owner's buy-out is good for both sides of the new partnership; it’s a win-win situation."

HemaTec, which is based in Germany’s Oberpfalz region, manufactures and installs large components for locks, weirs and flood barriers, including drive technology. With a considerable machine park in the field of large-part machining at the main sites as well as a small-parts production, HemaTec also operates in the field of contract metalworking. In recent years, HemaTec has realised remarkable lighthouse projects, including some of Germany's most technically challenging lock structures.

The investment company VORSPRUNG, based in Hamburg, is managed by Florian Lahnstein and invests long-term capital in SMEs from the DACH region. Supported by European entrepreneurial families, VORSPRUNG acquires holdings and pursues a buy-hold-develop strategy in which the target company is professionalised, developed and expanded together with the founders and the management team. Co-investor in the above transaction is the family holding company VAERING.

The Oppenhoff team, led by Dr. Gabriele Fontane (M&A/Private Equity) and Dr. Sebastian Zeeck (Corporate/M&A), consisted of Jan Kaminski, Robert Fischer-Sonnberg, Bennet Stephan (all Corporate/M&A), Jan Mohrmann, Hanjo Prondzinski (Tax), Marvin Rochner, Dr. Stefanie Minzenmay (Real Estate) and Dr. Simon Spangler (Antitrust).

Oppenhoff regularly advises on corporate transactions, most recently for example WOLF on the sale of its metal processing and welding technology division to the Munich-based private equity house Accursia Capital, the DEPPE group of companies on its battery recycling joint venture with Fahrzeug-Werke Lueg AG and the MRH Trowe Group on the acquisition of Lurse AG.

 

Back to list

Dr. Gabriele Fontane

Dr. Gabriele Fontane

PartnerAttorney

Bockenheimer Landstraße 2-4
60306 Frankfurt am Main
T +49 69 707968 172
M +49 162 2703 858

Email

Dr. Sebastian Zeeck<br/>LL.M.

Dr. Sebastian Zeeck
LL.M.

PartnerAttorney

Am Sandtorkai 74
20457 Hamburg
T +49 (0) 40 808105 530
M +49 172 8829 119

Email

LinkedIn